Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AMS.L Stock Summary
Top 10 Correlated ETFs
AMS.L
In the News
AMS.L Financial details
Company Rating
Buy
Market Cap
404.81M
Income
36.3M
Revenue
250.54M
Book val./share
-
Cash/share
-
Dividend
0.02
Dividend %
1.06%
Employees
800
Optionable
No
Shortable
Yes
Earnings
13 Mar 2024
P/E
22.14
Forward P/E
1781.82
PEG
2.85
P/S
3.64
P/B
1.91
P/C
-
P/FCF
26.76
Quick Ratio
3.63
Current Ratio
5.82
Debt / Equity
0
LT Debt / Equity
-
-
-
EPS (TTM)
0.17
EPS next Y
0.11
EPS next Q
-
EPS this Y
-21.87%
EPS next Y
-36.87%
EPS next 5Y
-32.34%
EPS last 5Y
-3.53%
Revenue last 5Y
4.28%
Revenue Q/Q
0.05%
EPS Q/Q
-22.33%
-
-
-
-
SMA20
-9.39%
SMA50
-10.08%
SMA100
-5.64%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
9%
ROC
0.1%
Gross Margin
59%
Oper. Margin
20%
Profit Margin
16%
Payout
21%
Shs Outstand
216.94M
Shs Float
210.91M
-
-
-
-
Target Price
-
52W Range
165.6-261.0
52W High
-24.9%
52W Low
+18.79%
RSI
46.57
Rel Volume
1.61
Avg Volume
418.55K
Volume
675.23K
Perf Week
1.55%
Perf Month
-5.08%
Perf Quarter
7.69%
Perf Half Y
-0.2%
-
-
-
-
Beta
0.578
-
-
Volatility
3.27%, 10.5%
Prev Close
3.16%
Price
196
Change
4.81%
AMS.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.48 | 0.4 | 0.5 | 0.57 | 0.58 | |
Net income per share | 0.09 | 0.04 | 0.08 | 0.09 | 0.07 | |
Operating cash flow per share | 0.1 | 0.1 | 0.14 | 0.13 | 0.07 | |
Free cash flow per share | 0.07 | 0.07 | 0.11 | 0.08 | 0.02 | |
Cash per share | 0.3 | 0.25 | 0.34 | 0.38 | 0.28 | |
Book value per share | 0.89 | 0.94 | 0.99 | 1.09 | 1.13 | |
Tangible book value per share | 0.24 | 0.1 | 0.18 | 0.21 | 1.13 | |
Share holders equity per share | 0.89 | 0.94 | 0.99 | 1.09 | 1.13 | |
Interest debt per share | 0.01 | 0.06 | 0.05 | 0.05 | 0.01 | |
Market cap | 635.6M | 522.76M | 728.99M | 560.77M | 447.99M | |
Enterprise value | 581.21M | 480.05M | 665.88M | 488.25M | 396.97M | |
P/E ratio | 33.6 | 60.9 | 41.7 | 27.48 | 28.19 | |
Price to sales ratio | 6.21 | 6.02 | 6.71 | 4.51 | 3.55 | |
POCF ratio | 29.68 | 24.83 | 23.97 | 20.71 | 31 | |
PFCF ratio | 40.85 | 33.1 | 30.44 | 32.76 | 97.3 | |
P/B Ratio | 3.32 | 2.59 | 3.43 | 2.37 | 1.83 | |
PTB ratio | 3.32 | 2.59 | 3.43 | 2.37 | 1.83 | |
EV to sales | 5.68 | 5.53 | 6.13 | 3.93 | 3.15 | |
Enterprise value over EBITDA | 17.32 | 25.92 | 22.61 | 13.97 | 12.93 | |
EV to operating cash flow | 27.14 | 22.8 | 21.9 | 18.03 | 27.47 | |
EV to free cash flow | 37.36 | 30.4 | 27.81 | 28.53 | 86.22 | |
Earnings yield | 0.03 | 0.02 | 0.02 | 0.04 | 0.04 | |
Free cash flow yield | 0.02 | 0.03 | 0.03 | 0.03 | 0.01 | |
Debt to equity | 0.01 | 0.05 | 0.05 | 0.04 | 0 | |
Debt to assets | 0.01 | 0.05 | 0.04 | 0.03 | 0 | |
Net debt to EBITDA | -1.62 | -2.31 | -2.14 | -2.08 | -1.66 | |
Current ratio | 6.51 | 6.6 | 6.76 | 5.82 | 5.67 | |
Interest coverage | 70.69 | 13.57 | 18.76 | 40.9 | 13.17 | |
Income quality | 1.13 | 2.45 | 1.74 | 1.33 | 0.91 | |
Dividend Yield | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.16 | 0.39 | 0.22 | 0.21 | 0.3 | |
Sales general and administrative to revenue | 0.34 | 0.39 | 0.34 | 0.38 | 0 | |
Research and developement to revenue | 0.03 | 0.04 | 0.04 | 0.03 | 0.04 | |
Intangibles to total assets | 0.62 | 0.75 | 0.69 | 0.68 | 0 | |
Capex to operating cash flow | -0.27 | -0.25 | -0.21 | -0.37 | -0.68 | |
Capex to revenue | -0.06 | -0.06 | -0.06 | -0.08 | -0.08 | |
Capex to depreciation | -1 | -0.77 | -0.73 | -1.13 | -0.91 | |
Stock based compensation to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0 | |
Graham number | 1.33 | 0.92 | 1.34 | 1.52 | 1.37 | |
ROIC | 0.11 | 0.05 | 0.07 | 0.08 | 0.06 | |
Return on tangible assets | 0.22 | 0.15 | 0.23 | 0.22 | 0.05 | |
Graham Net | 0.28 | 0.21 | 0.29 | 0.31 | 0.24 | |
Working capital | 94.58M | 82.46M | 97.97M | 109.23M | 100.74M | |
Tangible asset value | 50.79M | 22.35M | 39.66M | 46.53M | 244.2M | |
Net current asset value | 76.01M | 60.83M | 78.14M | 87.44M | 77.35M | |
Invested capital | 0.01 | 0.05 | 0.05 | 0.04 | 0 | |
Average receivables | 27.01M | 25.84M | 22.51M | 22.22M | 23.93M | |
Average payables | 5.68M | 7.1M | 5.83M | 5.65M | 12.84M | |
Average inventory | 16.23M | 19.34M | 20.16M | 23.61M | 31.98M | |
Days sales outstanding | 104.65 | 93.87 | 76.32 | 63.81 | 75.53 | |
Days payables outstanding | 60.61 | 56.18 | 33.92 | 42.04 | 112.47 | |
Days of inventory on hand | 144.55 | 173.93 | 134.22 | 182.87 | 210.57 | |
Receivables turnover | 3.49 | 3.89 | 4.78 | 5.72 | 4.83 | |
Payables turnover | 6.02 | 6.5 | 10.76 | 8.68 | 3.25 | |
Inventory turnover | 2.53 | 2.1 | 2.72 | 2 | 1.73 | |
ROE | 0.1 | 0.04 | 0.08 | 0.09 | 0.07 | |
Capex per share | -0.03 | -0.02 | -0.03 | -0.05 | -0.05 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.27 | 0.27 | 0.3 | 0.29 | 0 | |
Net income per share | 0.04 | 0.04 | 0.05 | 0.04 | 0 | |
Operating cash flow per share | 0.08 | 0.06 | 0.07 | 0.02 | 0 | |
Free cash flow per share | 0.06 | 0.04 | 0.04 | 0 | 0 | |
Cash per share | 0.34 | 0.35 | 0.38 | 0.32 | 0 | |
Book value per share | 0.99 | 1.02 | 1.09 | 1.12 | 0 | |
Tangible book value per share | 0.18 | 0.16 | 0.21 | 0.13 | 0 | |
Share holders equity per share | 0.99 | 1.02 | 1.09 | 1.12 | 0 | |
Interest debt per share | 0.05 | 0.05 | 0.05 | 0.05 | 0 | |
Market cap | 729.06M | 638M | 560.7M | 490.3M | 0 | |
Enterprise value | 665.96M | 572.09M | 488.19M | 430.34M | -51.02M | |
P/E ratio | 21.32 | 16.5 | 13.05 | 13.72 | 0 | |
Price to sales ratio | 12.48 | 10.94 | 8.49 | 7.77 | 0 | |
POCF ratio | 42.77 | 51.52 | 38.15 | 96.18 | 0 | |
PFCF ratio | 54.29 | 78.55 | 62.34 | 1.74K | 0 | |
P/B Ratio | 3.43 | 2.89 | 2.37 | 2.02 | 0 | |
PTB ratio | 3.43 | 2.89 | 2.37 | 2.02 | 0 | |
EV to sales | 11.4 | 9.81 | 7.39 | 6.82 | -0.81 | |
Enterprise value over EBITDA | 40.59 | 35.36 | 28.59 | 28.51 | -3.74 | |
EV to operating cash flow | 39.07 | 46.2 | 33.22 | 84.41 | -5.45 | |
EV to free cash flow | 49.59 | 70.44 | 54.28 | 1.53K | -11.8 | |
Earnings yield | 0.01 | 0.02 | 0.02 | 0.02 | 0 | |
Free cash flow yield | 0.02 | 0.01 | 0.02 | 0 | 0 | |
Debt to equity | 0.05 | 0.04 | 0.04 | 0.04 | 0 | |
Debt to assets | 0.04 | 0.04 | 0.03 | 0.03 | 0 | |
Net debt to EBITDA | -3.85 | -4.07 | -4.25 | -3.97 | -3.74 | |
Current ratio | 6.76 | 5.65 | 5.82 | 5.53 | 5.67 | |
Interest coverage | 15.37 | 35.64 | 37.13 | 11.46 | 12.45 | |
Income quality | 1.99 | 1.28 | 1.37 | 0.57 | 1.34 | |
Dividend Yield | 0 | 0 | 0 | 0.01 | 0 | |
Payout ratio | 0.15 | 0.31 | 0.13 | 0.37 | 0.22 | |
Sales general and administrative to revenue | 0.35 | 0.37 | 0.39 | 0.39 | 0 | |
Research and developement to revenue | 0.01 | 0.06 | 0.01 | 0.05 | 0 | |
Intangibles to total assets | 0.69 | 0.7 | 0.68 | 0.74 | 0 | |
Capex to operating cash flow | -0.21 | -0.34 | -0.39 | -0.94 | -0.54 | |
Capex to revenue | -0.06 | -0.07 | -0.09 | -0.08 | -0.08 | |
Capex to depreciation | -0.76 | -1.02 | -1.22 | -0.93 | -0.89 | |
Stock based compensation to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0 | |
Graham number | 0.94 | 1.01 | 1.1 | 1.02 | 0 | |
ROIC | 0.04 | 0.04 | 0.04 | 0.03 | 0.02 | |
Return on tangible assets | 0.11 | 0.12 | 0.12 | 0.12 | 0.02 | |
Graham Net | 0.29 | 0.28 | 0.31 | 0.25 | 0 | |
Working capital | 97.97M | 98.96M | 109.23M | 103.01M | 100.74M | |
Tangible asset value | 39.66M | 35.13M | 46.53M | 27.76M | 244.2M | |
Net current asset value | 78.14M | 76.68M | 87.44M | 76.93M | 77.35M | |
Invested capital | 0.05 | 0.04 | 0.04 | 0.04 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 35 | 34.21 | 29.63 | 35.37 | 37.24 | |
Days payables outstanding | 47.73 | 63.31 | 63.02 | 62.15 | 54.27 | |
Days of inventory on hand | 61.58 | 78.12 | 85.09 | 93.71 | 101.6 | |
Receivables turnover | 2.57 | 2.63 | 3.04 | 2.54 | 2.42 | |
Payables turnover | 1.89 | 1.42 | 1.43 | 1.45 | 1.66 | |
Inventory turnover | 1.46 | 1.15 | 1.06 | 0.96 | 0.89 | |
ROE | 0.04 | 0.04 | 0.05 | 0.04 | 0.03 | |
Capex per share | -0.02 | -0.02 | -0.03 | -0.02 | 0 |
AMS.L Frequently Asked Questions
What is Advanced Medical Solutions Group plc stock symbol ?
Advanced Medical Solutions Group plc is a GB stock and trading under the symbol AMS.L
What is Advanced Medical Solutions Group plc stock quote today ?
Advanced Medical Solutions Group plc stock price is $196 today.
Is Advanced Medical Solutions Group plc stock public?
Yes, Advanced Medical Solutions Group plc is a publicly traded company.